Registry study for a new stomach pacemaker
Part of Digestive system clinical trials.
This study records outcomes for people who need a new implanted stomach electrical stimulation device for severe stomach emptying problems (gastroparesis) that haven’t improved with usual treatments. It may help doctors learn which patients benefit most and how to manage the device over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are planning to get a newly implanted stomach electrical stimulation device
- You have severe gastroparesis that hasn’t responded to standard care
- You can move around on your own and are not bed-ridden or living in a nursing facility
- If you can become pregnant, you are not currently pregnant
- You can give your own informed consent (or confirm you can do so)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with drug-refractory gastroparesis (stomach paralysis symptoms that don’t improve with usual medicines) to better understand how symptoms and nutrition change over time. Your information may help researchers understand patterns that could improve care.
This study tests a new way to program the Enterra stomach pacemaker so it cycles at night, aiming to improve gastroparesis symptoms. It's for people who already have the device and have stable symptoms.
This study looks at how a special implanted device that sends gentle electrical pulses to your stomach can help reduce chronic belly pain caused by gastroparesis (a condition where the stomach doesn't empty food properly). You must already have this device implanted and be experiencing moderate to severe daily pain.
This study uses a non-invasive stomach-mapping test (BSGM) to see if a G-POEM procedure (a treatment for gastroparesis) works well. It may help doctors better understand how the stomach empties after the procedure.
This study tests a non-invasive treatment called percutaneous electrical nerve field stimulation to see if it can help control symptoms like nausea and vomiting in people with diabetes-related gastroparesis. It aims to ease digestive symptoms and calm overactive nerves.
This study collects small tissue samples from the stomach and upper small intestine while you’re already having certain kinds of GI (digestive) or abdominal surgery. It aims to learn what causes stomach or bowel movement problems in some patients, which could guide future diagnosis and care.
Hear when a new Gastroparesis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.